Satiogen Pharmaceuticals, Inc.

Calculating rank

USPTO Granted Patents = 9

% Expired Patents = 22.2

CIPO Patents = 1

EPO Patents = 2

Forward Citations = 61

Loading Chart...

3 inventors (with patents filed for the assignee):

Andrew A Young (9 out of 68 patents)

Bronislava Gedulin (8 out of 26 patents)

Howard E Greene (8 out of 10 patents)

9 patents: Sort by Forward Citations

1. 11260053 - Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions (2022-03-01),

2. 10555950 - Bile acid recycling inhibitors for treatment of obesity and diabetes (2020-02-11),

3. 10251880 - Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions (2019-04-09),

4. 10188646 - Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions (2019-01-29),

5. 10028952 - Methods of treating diabetes or obesity using bile acids, bile salts, and mimics thereof (2018-07-24),

6. 9345715 - Methods of treating diabetes or obesity using bile acids, bile salts, and mimics thereof (2016-05-24),

7. 9339480 - Bile acid recycling inhibitors for treatment of obesity and diabetes (2016-05-17),

8. 8366650 - Biliary/pancreatic shunt device and method for treatment of metabolic and other diseases (2013-02-05),

9. 8318663 - Methods of treating diabetes and/or obesity using an enteroendocrine peptide secretion enhancing agent (2012-11-27),

Company Overview

Satiogen Pharmaceuticals, Inc. is a cutting-edge biopharmaceutical company focused on developing innovative therapies for various medical conditions. Our team of experts is dedicated to advancing research and delivering breakthrough treatments that improve the health and well-being of patients worldwide. With a strong commitment to scientific excellence and patient care, Satiogen is revolutionizing the pharmaceutical industry and shaping the future of medicine.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

9 Patents

#580 in San Diego, CA

#7,751 in California

#32,624 in US

San Diego, CA, United States of America

Satiogen Pharmaceuticals, Inc.

Forward Citations = 61

3 inventors:

Andrew A Young (9 out of 68 patents)

Bronislava Gedulin (8 out of 26 patents)

Howard E Greene (8 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Satiogen Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/satiogen-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]